ISIN | IE00BWBXM617 |
---|---|
Valor Number | 28805622 |
Bloomberg Global ID | |
Fund Name | SPDR S&P U.S. Health Care Select Sector UCITS ETF USD |
Fund Provider |
State Street Global Advisors
Beethovenstrasse 19, 8002 Zürich E-Mail: Switzerland_ICG_team@ssga.com Web: www.ssga.com spdrsswitzerland@ssga.com (ETF Business) |
Fund Provider | State Street Global Advisors |
Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
Distributor(s) | State Street Global Advisors |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Ireland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Fund is to track the performance of large sized U. S. health care companies in the S&P 500 Index. |
Peculiarities |
Current Price * | 47.54 USD | 16.09.2024 |
---|---|---|
Previous Price * | 47.23 USD | 13.09.2024 |
52 Week High * | 47.56 USD | 02.09.2024 |
52 Week Low * | 36.90 USD | 27.10.2023 |
NAV * | 47.54 USD | 16.09.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 418,540,242 | |
Unit/Share Assets *** | 418,540,242 | |
Trading Information SIX |
YTD Performance | +15.92% |
29.12.2023 - 16.09.2024
29.12.2023 16.09.2024 |
---|---|---|
YTD Performance (in CHF) | +16.82% |
29.12.2023 - 16.09.2024
29.12.2023 16.09.2024 |
1 month | +2.78% |
16.08.2024 - 16.09.2024
16.08.2024 16.09.2024 |
3 months | +8.22% |
17.06.2024 - 16.09.2024
17.06.2024 16.09.2024 |
6 months | +8.78% |
18.03.2024 - 16.09.2024
18.03.2024 16.09.2024 |
1 year | +20.65% |
18.09.2023 - 16.09.2024
18.09.2023 16.09.2024 |
2 years | +26.57% |
16.09.2022 - 16.09.2024
16.09.2022 16.09.2024 |
3 years | +22.90% |
16.09.2021 - 16.09.2024
16.09.2021 16.09.2024 |
5 years | +84.85% |
16.09.2019 - 16.09.2024
16.09.2019 16.09.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 13.20% | |
---|---|---|
UnitedHealth Group Inc | 9.37% | |
Johnson & Johnson | 6.88% | |
AbbVie Inc | 5.97% | |
Merck & Co Inc | 5.17% | |
Thermo Fisher Scientific Inc | 4.05% | |
Abbott Laboratories | 3.40% | |
Amgen Inc | 3.08% | |
Danaher Corp | 3.06% | |
Intuitive Surgical Inc | 3.01% | |
Last data update | 31.08.2024 |
TER *** | 0.15% |
---|---|
TER date *** | 31.03.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.15% |
Ongoing Charges *** | 0.15% |
SRRI ***
|
|
SRRI date *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |